Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aspen Aerogels (ASPN) EBT (2016 - 2025)

Historic EBT for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to -$5.7 million.

  • Aspen Aerogels' EBT rose 5481.38% to -$5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$303.0 million, marking a year-over-year decrease of 905539.46%. This contributed to the annual value of $15.1 million for FY2024, which is 13293.75% up from last year.
  • Latest data reveals that Aspen Aerogels reported EBT of -$5.7 million as of Q3 2025, which was up 5481.38% from -$8.2 million recorded in Q2 2025.
  • Aspen Aerogels' EBT's 5-year high stood at $17.7 million during Q2 2024, with a 5-year trough of -$300.2 million in Q1 2025.
  • Its 5-year average for EBT is -$24.7 million, with a median of -$11.6 million in 2021.
  • As far as peak fluctuations go, Aspen Aerogels' EBT surged by 225549.13% in 2024, and later tumbled by 2771955.51% in 2025.
  • Over the past 5 years, Aspen Aerogels' EBT (Quarter) stood at -$16.4 million in 2021, then surged by 41.24% to -$9.6 million in 2022, then surged by 94.6% to -$519000.0 in 2023, then skyrocketed by 2255.49% to $11.2 million in 2024, then plummeted by 151.31% to -$5.7 million in 2025.
  • Its last three reported values are -$5.7 million in Q3 2025, -$8.2 million for Q2 2025, and -$300.2 million during Q1 2025.